The University Hospital Heidelberg is one of the oldest and largest medical institutions in Europe. It is especially known for innovative cancer care and cancer research, together with its partner institutions, the National Center for Tumor Diseases and the German Cancer Research Center in Heidelberg.
For the EU Horizon project ThermoBreast, the design and conduction of the clinical trial will be led by clinical researchers from the University Hospital Heidelberg. University Hospital Heidelberg is one of the partner clinical sites where the ThermoBreast clinical study is conducted in Germany. It is currently recruiting patients in Heidelberg. To learn more about how to participate in the ThermoBreast clinical study, please contact studien.senologie@med.uni-heidelberg.de.
University Hospital Heidelberg
Clinical Study Lead
University Hospital Heidelberg
Clinical Study Lead
University Hospital Heidelberg, Cllinical Study Lead
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them (grant agreement no. 101096329).
Swiss participants in this project are supported by the Swiss State Secretariat for Education, Research and Innovation (contract no. 22.00518).
